Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | 1 | 0 | 0 | 0 | €20.40 | - | - |
| Rhythm Pharmaceuticals | 14 | 0 | 0 | 0 | €40.40 | €46.19 | 14.319% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.10 | €2.40 | 117.391% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €15.09 | €24.44 | 61.930% |
| Novo Nordisk A/S | 5 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Trinity Biotech ADR | 27 | 0 | 0 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €1.83 | €4.00 | 118.579% |
| Verastem Inc. | 12 | 0 | 0 | 0 | €2.30 | €17.56 | 663.304% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €2.27 | €4.39 | 93.620% |
| UCB S.A. | 1 | 0 | 0 | 0 | €154.15 | - | - |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.08 | €35.01 | 34.223% |
| Bausch Health Companies Inc. | 5 | 0 | 0 | 0 | €5.16 | €16.47 | 219.579% |
| Dynavax Technologies Corp | 3 | 0 | 0 | 0 | €10.35 | €27.02 | 161.154% |
| Cytokinetics Inc. | 31 | 1 | 0 | 0 | €52.50 | €84.53 | 61.009% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €104.60 | €109.00 | 4.207% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €8.67 | - | - |
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 0 | 0 | €8.14 | €28.29 | 247.600% |
| Codexis Inc. | 6 | 1 | 0 | 0 | €3.02 | €8.36 | 176.795% |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 14 | 9 | 0 | 0 | €29.00 | €41.46 | 42.976% |
| Intra-Cellular Therapies Inc. | 28 | 0 | 0 | 0 | €71.00 | €84.46 | 18.952% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.14 | €3.64 | 219.404% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.22 | - | - |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 0 | 0 | €24.01 | €54.98 | 128.992% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €122.00 | €150.00 | 22.951% |